Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Sniderman

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
The Netherlands Journal of Medicine|July 14, 2005
If apoB is so good, why isn't everybody measuring it? One reason why we need The Netherlands Journal of Medicine!A D Sniderman, M Rosenbloom
Clinical Chemistry|April 1, 1996
Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemiasA D Sniderman, K Cianflone
The Canadian Journal of Cardiology|February 29, 2000
Lipids and cardiovascular diseasesA D Sniderman, J Frohlich
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1995
Metabolic disruptions in the adipocyte-hepatocyte fatty acid axis as causes of HyperapoBA D Sniderman, K Cianflone
Current Opinion in Lipidology|August 1, 1994
Angiogenesis: potential therapy for ischaemic diseaseJ F Symes, A D Sniderman
Preventive Medicine|November 1, 1983
Atherosclerosis and apoproteins B and A-IP O Kwiterovich, A D Sniderman
The Canadian Journal of Cardiology|October 1, 1990
Inspiratory reduction in left heart filling as a mechanism of pulsus paradoxus in cardiac tamponadeD H Fitchett, A D Sniderman
International Journal of Cardiology|August 1, 1988
Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failureA D Sniderman, D H Fitchett
Diabetologia|July 1, 1997
The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoBA D Sniderman, K Cianflone, K Frayn
The Biochemical Journal|May 23, 2001
Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytesT Scantlebury, A D Sniderman, K Cianflone
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
The Netherlands Journal of Medicine|July 14, 2005
If apoB is so good, why isn't everybody measuring it? One reason why we need The Netherlands Journal of Medicine!A D Sniderman, M Rosenbloom
Clinical Chemistry|April 1, 1996
Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemiasA D Sniderman, K Cianflone
The Canadian Journal of Cardiology|February 29, 2000
Lipids and cardiovascular diseasesA D Sniderman, J Frohlich
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1995
Metabolic disruptions in the adipocyte-hepatocyte fatty acid axis as causes of HyperapoBA D Sniderman, K Cianflone
Current Opinion in Lipidology|August 1, 1994
Angiogenesis: potential therapy for ischaemic diseaseJ F Symes, A D Sniderman
Preventive Medicine|November 1, 1983
Atherosclerosis and apoproteins B and A-IP O Kwiterovich, A D Sniderman
The Canadian Journal of Cardiology|October 1, 1990
Inspiratory reduction in left heart filling as a mechanism of pulsus paradoxus in cardiac tamponadeD H Fitchett, A D Sniderman
International Journal of Cardiology|August 1, 1988
Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failureA D Sniderman, D H Fitchett
Diabetologia|July 1, 1997
The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoBA D Sniderman, K Cianflone, K Frayn
The Biochemical Journal|May 23, 2001
Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytesT Scantlebury, A D Sniderman, K Cianflone
Pageof 14